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Background: Tyrosinase, as a copper-containing enzyme, is widely distributed in different levels of life span. It is also a key enzyme in melanin biosynthesis, which plays a crucial role in determining the color of mammalian skin and hair.
Objectives: The current study aimed to determine the effect of a palladium complex on cresolase and catecholase reactions of mushroom tyrosinase (MT).
Materials and Methods: The MT kinetics parameters were obtained from double reciprocal plots of Lineweaver-Burk and the inhibition constants (Ki) were determined by the secondary plots. Thermodynamic parameters were obtained from thermal and chemical denaturation of the tyrosinase with and without the presence of palladium complex. The tertiary and secondary structures of tyrosinase were detected by fluorescent and Circular Dichroism (CD) techniques.
Results: The inhibition modes of palladium complex were competitive in both activities of the enzyme with Ki values of 3.74 and 10.55 
μM for cresolase and catecholase activities, respectively. In thermal denaturation, the melting points (Tm) of the enzyme were 59.4˚C and 51˚C for the sole enzyme and its treatment by palladium, respectively. In chemical denaturation, the magnitudes of half denaturant concentration (Cm) were 1 μM vs. 1.36μM and the free energy of Gibss (ΔGH2O) were calculated 9.3 vs. 7.5 kJ/M for the sole enzyme and its treatment by palladium, respectively.
Conclusions: In overall the palladium complex acted as a good inhibitor of tyrosinase and induced the enzyme thermodynamic and conformational instability, therefore it can be considered in the hyper expression of tyrosinase in melanoma cancer.
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1. BackgroundTyrosinase (EC 1.14.18.1), as a bifunctional enzyme, cata-lyzes the o-hydroxylation of monophenols to the corre-sponding catechols (cresolase activity), and the oxidation of catechols to the corresponding o-quinones (catecho-lase activity). The enzyme active site can be found in three met, deoxy, and oxy forms (1). Structural models for the active site of these three enzyme forms are proposed by considering its binding with oxygen (2). The common mushroom tyrosinase (MT) from the species Agaricus bisporus is a copper containing enzyme with a molecular mass of 120 kD composed of two H subunits (43 kD) and two L subunits (13 kD) and has two active sites. The active sites include a pair of copper ions, each bound with three conserved histidine residues (3). After the two consecu-tive cresolase and catecholase activities as the enzymatic reactions and production of ortho-quinones, they can polymerize non-enzymatically to melanin as the most important natural biopolymer responsible for pigmen-tation and the color and patterns of mammalian skin. The production of abnormal melanin pigmentation (melasma, freckles, ephelide, senile lentigines, etc.) is a 
serious esthetic problem in human beings (4). Tyrosinase pigments can be detected in the mammals' brains (5). Ty-rosinase may play a role in neuromelanin formation in the human brain, -be central to dopamine neurotoxic-ity ,and contribute to the neurodegeneration associated with the Parkinson (6). The enzyme can be utilized in pharmaceutical, cosmetic, and hygienic productions (7). Many tyrosinase inhibitors that suppress melanogenesis are actively studied to develop hyper pigmentation treat-ment (8-10). The studies showed that palladium complex-es could restrict multiplication of some groups of tumor cells sensitive to cisplatin (e. g. pam212, vero, Hela) as well as some others resistant to cisplatinum (e. g. pam-ras) (11, 12). Besides, palladium complexes are less toxic in kidneys than - cisplatinum. Considering the aforementioned rea-sons, palladium complexes can be widely used to treat different kinds of diseases (13, 14). It is reported that the failure of cisplatin to treat tumors of gastrointestinal region is mainly due to high concentration of chloride in this region (15). However, since palladium complexes, containing chelating ligands, do not interact with chlo-
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ride ions, they can be useful to track tumors of the gas-trointestinal. Mushroom tyrosinase is popular among re-searchers since it is commercially available, inexpensive, and the features of this enzyme can be easily investigat-ed. Yet some important aspects of the enzyme structure, mechanism, and behavior are unresolved. Therefore, in pursuit of the kinetic, stability and the effects of inhibi-tors in the structure- function relationship of MT (16-20), the current study focused on the assessment of a palladi-um complex as an inhibitor on the kinetic, stability and structure of the MT. As mentioned above, tyrosinase was studied from different points of view, in particular edible MT, because of its availability and close similarity with mammals’ tyrosinase.
2. ObjectivesThe current study planned to evaluate the effects of a palladium complex on the activity, stability, and struc-ture of the tyrosinase enzyme.
3. Materials and Methods
3.1. ChemicalsMushroom tyrosinase (MT; EC1.14.18.1), specific activity 3400 IU/mg, was purchased from Sigma Company. Caffeic acid and p-coumaric acid were available from the authen-tic samples. The 50 mM phosphate buffer with pH 6.8 was used in the assay, and the salts (K2HPO4 and KH2PO4) were obtained from Merck Company (Germany). All the experi-ments were carried out at 293 K. The palladium complex (934 kD) was used as the synthetic compound in the cur-rent study. 
3.2. Kinetic Assays of Catecholase and Cresolase ActivitiesThe kinetic assays of catecholase and cresolase activities were carried out by Cary spectrophotometer apparatus (100 Bio model), using water-jacketed cell holders. Fresh-ly prepared enzyme, substrate, and inhibitor were used in the current work. All enzymatic reactions were run in phosphate buffer (50 mM) at pH = 6.8 in a conventional quartz cell thermo stated to maintain the temperature at 20 ± 0.1°C. The selected conditions of the solvent, buf-fer, pH, temperature, and enzyme concentration were applied to assay the oxidase activity of the MT according to the authors` previous studies (19). Inhibition of the MT by palladium complex was studied using caffeic acid (cat-echolase activity) and p-coumaric acid (cresolase activity) as substrates. Catecholase activity was followed by deple-tion of caffeic acid for two minutes at its maximum wave-length of 311 nm and enzyme concentration of 40 IU/mL. The reactions were carried out using different concentra-
tions of the inhibitors (12, 18, 25, 31, and 37 μM). Cresolase reactions were measured by depletion of p-coumaric acid for 10 minutes at its maximum wavelength of 288 nm and 
enzyme concentration of 120 IU/mL. The reactions were followed using different concentrations of the inhibitors 
(12, 18, 25, 31, and 37 μM). All of the assays were repeated at least three times. The inhibition type was determined by the Lineweaver-Burk plot, and the inhibition constant (Ki) of the tyrosinase activity were determined by the secondary plots of the apparent Km/Vm or 1/Vm versus the concentration of the inhibitor.
3.3. Intrinsic Fluorescence Analysis of the MTFluorescent thermal intensity measurements were car-ried out on a spectrofluorimeter apparatus (Cary Eclipse, model 100) equipped with a thermostatically controlled cuvette compartment. Thermal denaturation of the MT with 0.2 mg/mL concentration was obtained in a vari-able temperature from 25˚C to 95 ˚C in the absence and presence of palladium complex. The sigmoid curve from emission spectra of the MT was recorded after excitation at 280 nm and emission at 350 nm in increments of 1 nm. For tertiary structure analysis of the MT (0.2 mg/mL) the emission spectra were obtained in the excitation wave-length of 280 nm and the emission wavelength ranged between 300 and 450 nm in the absence and presence of palladium complex (8, 16, and 24 µM).
3.4. Circular Dichroism SpectroscopyThe far-UV Circular Dichroism (CD) region (190-260 nm), which corresponds to peptide bond absorption, was analyzed by an Aviv model 215 spectropolarimeter to give the content of regularly secondary structure in the MT. Protein solutions were prepared in the phosphate buffer. The protein solutions of 0.2 mg/mL without and with in-cubation by different concentrations were used to obtain the spectra. All spectra were collected in triplicate from 190 to 260 nm against a background-corrected buffer blank. The results were expressed as mdegcm.
4. ResultsWhen using Caffeic acid and p-coumaric acid as sub-strates, it is possible to assay both monooxygenase (cre-solase) and oxidase (catecholase) activities of the MT di-rectly through the rate of substrate depletion. To obtain the kinetic parameters, biochemists usually select a lim-ited range of substrate concentration in which the en-zyme comply with the Michaelis–Menten equation. The resulting kinetic graph is then analyzed by the double-re-ciprocal method which produces the related Lineweaver-Burk plots.
4.1. Cresolase Reactions of the MTDouble reciprocal Lineweaver-Burk plots for the cre-solase activity of the MT on hydroxylation of p-coumaric acid, as the substrate, in the presence of different concen-trations of palladium complex are shown in (Figure 1 A). They show a series of straight lines that intersect each 
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Figure 1. A, Double reciprocal Lineweaver-Burk plots of the MT kinetic as-says for cresolase reaction of p-coumaric acid in the presence of different fixed concentrations of inhibitor compounds: 0 (∆)،, 12(●) ,18 (◊), 25 (▲), 31(◊), 37 (○); B, the secondary plots with an abscissa intercept of -Ki.
other exactly on the vertical axis. The maximum velocity (Vmax) is not changed by palladium complex, but the ap-parent Michaelis constant (Km) value is increased, which confirms the competitive mode of the inhibition. The Fig-ure 1 B shows the secondary plot, the slopes versus differ-ent concentrations of palladium complex as inhibitor. The inhibition constants (Ki) can be calculated from the 
abscissa-intercepts. Here the Ki value was 3.74 μM.4.2. Catecholase Reactions of the MTDouble reciprocal Lineweaver-Burk plots for the cat-echolase activity of the MT on oxidation of caffeic acid, as the substrate, in the presence of different concentra-tions of palladium complex are shown in Figure 2 A. Here again the straight lines intersect on the vertical axis due to competitive inhibition of the enzyme by the inhibi-tor. The Ki value obtained from the abscissa-intercept of the secondary plot (Figure 2 B). The value of Ki as the 
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Figure 2. A, Double reciprocal Lineweaver-Burk plots of the MT kinetic as-says for catecholase reaction of caffeic acid in the presence of different fixed concentrations of palladium complex as inhibitor compound: 0 (∆)،, 12(●) ,18 (◊) , 25 (▲), 31(◊), 37 (○); B, the secondary plots with an ab-scissa intercept of -Ki.
inhibitory constant of palladium complex on the MT cat-
echolase reaction was 10.55 μM.4.3. Chemical and Thermal DenaturationExamining inactivity of the enzyme under thermal stress condition to study its stability can be done by en-zyme solution in the density of 0.2 mg/mL with and with-out the presence of the inhibitor. The excitation wave-length was 280 nm and the maximum emission intensity wavelength was obtained in 350 nm, then thermal scan was done in 25°C -90°C. Chemical and thermal stability of the MT was assessed in the absence and presence of palla-dium complex. Chemical and thermal denaturation pro-files were obtained from urea titration and thermal scan-ning, respectively. These sigmoid curves were obtained in the absence and presence of palladium complex and depicted in Figure 3A-B and 4. The determination of stan-
dard Gibbs free energy of denaturation (ΔG°), as a crite-
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rion of conformational stability of globular proteins, is based on two state theories as follows:Native (N) ↔ Denatured (D) (1)Assuming a two-state mechanism for enzyme chemical and thermal denaturations, one can determine the pro-cess by monitoring changes in the absorbance or fluo-rescent thermal intensity, and hence calculate the dena-tured fraction of protein (Fd) as well as determination of the equilibrium constant (K).Fd = (YN − Yobs)/(YN − YD) (2)K = (Fd)/(1 − Fd) = (YN − Yobs)/(Yobs − YD) (3)Where Yobs is the observed variable parameter (for ex-ample, absorbance or thermal intensity) and YN and YD are the values of Y characteristics of a fully native and de-natured conformation, respectively. The standard Gibbs 
free energy change (ΔG°) for protein denaturation is given by the following equation:
ΔG° = −RTlnK (4)Where R is the universal gas constant and T is the absolute 
temperature; ΔG° varies linearly with denaturant concen-tration ([urea]) and temperature (T) over a limited region.
ΔG° = ΔG°H2o − m [denaturant] (5)
ΔGH2O is the free energy of conformational stability in the absence of denaturant and m is a measure of the de-
pendence of ΔG° on the denaturant concentration, and 
ΔG25℃ (the standard Gibbs free energy of protein dena-turation at 25°C can be obtained by equation five of Pace 
analysis (21). The magnitudes of ΔG25℃ and ΔGH2O are the most valuable criterions of the enzyme conformational stability in the process of chemical and thermal denatur-ations, respectively. In the chemical denaturation, [Urea]1/2 is the denaturant concentration that the enzyme needs to reach half of its two-state transition. In the thermal dena-turation, protein melting point (Tm) is a temperature that the protein needs to reach half of its two-state transition. 
The magnitudes of ΔG25℃, ΔGH2O, [Urea]1/2 and the Tm de-termined from replots, are summarized in Table 1.4.4. Fluorescence Characteristics of the MTMeasuring the intensity of internal fluorescence of the MT with and without the presence of palladium complex was done in the excitation wavelength of 280 nm and emission range of 300-450 nm. As shown in Figure 5, the intrinsic fluorescence of the MT is very sensitive to its micro environment. The increment of palladium complex con-centration induced a gradual reduction of the fluorescence spectra intensity or the chromophore quenching and thus the conformational change of tertiary structure of the MT.
4.5. Circular Dichroism of the MTCircular Dichroism is widely used to determine the sec-ondary structure of macromolecules. The CD spectra of the MT in the absence and presence of palladium com-plex are shown in Figure 6. As observed in the figure, the negative elipticity of the enzyme showed more reduction in the presence of palladium complex.
Figure 3. Chemical Denaturation Profiles of the MT Obtained From Urea Titration
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A, Sole MT and B, MT with the presence of 10.55 µM palladium complex. In-
sert: Linear secondary plots to obtain ΔGH2O, and Cm as thermodynamic parameters.
Figure 4. Thermal Denaturation Profiles of the MT Obtained From Internal Fluorescence Intensity in 350 nm Emission Wavelength With Temperature Scanning
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Table 1.  Thermodynamic Parameters of the Sole Mushroom Ty-rosinase and Its Incubation With Palladium Complex a
Variables Chemical Denatur-
ation
Thermal Denatur-
ation
[UREA]1/2, M ΔG°H2O, kJ/M Tm, °C ΔG25°C, kJ/M
Sole MT 1 9.3 59.4 12.6
MT + Pd 1.36 7.5 51 8a Abbreviations: MT, mushroom tyrosinase.
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Figure 5. Internal fluorescence intensity of the MT with the concentra-tion of 0.2 mg/mL in the excitation wavelength of 280 nm and emission range of 300-450 nm after incubation with 0, 8, 16 and 24 µM palladium complex.
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Figure 6. Far UV-CD Spectra of the Sole MT and Its Incubation With 10.55 µM Palladium Complex
5. DiscussionThe results obtained from the effect of the palladium complex on MT cresolase and catecholase reactions in double reciprocal plots of Lineweaver-Burk showed its competitive manner of inhibition. The availability of crystallographic data of hemocyanins and recently of sweet potato catechol oxidase shows that in the model of the three-dimensional structure of the tyrosinase family, the catalytic copper center is accommodated in a central four-helix-bundle located in a hydrophobic pocket close to the surface (22). Ki is a dissociation constant of the en-zyme-inhibitor complex and its low values 1.4 and 10.55 µm for cresolase and catecholase reactions respectively, mentioned that the palladium complex was categorized as a strong inhibitor of MT. Besides, the complex competi-tive pattern of inhibition showed its proper interaction with the hydrophobic pocket that surrounded the MT ac-tive site. It is proposed that the palladium complex like the other compounds as a competitive inhibitor of the MT bind to the free copper through their active moieties attached to sp2 carbon (23, 24). The enzyme thermody-namic parameters from chemical and thermal dena-
turations, especially the amount of free energy ΔGH2O, 
ΔG25℃ and Tm of the MT after its incubation with palladi-um complex, showed occurrence of the enzyme instabili-ty. Palladium complex reduced the enzyme melting point (Tm) and induced its instability, which is in concord with fluorescence and CD structural changes. As shown in figure 5 the spectra of enzyme initial fluorescence inten-sity gradually reduced with the increment of palladium complex concentrations, therefore it changed the micro-environment of tryptophan and tyrosine residues in the enzyme and quenched these chromophores. When the protein is stimulated in 280 nm the tryptophan and tyro-sine amino acids are influenced, then the third structure of the protein would be transformed (25). It accompanies with the enzyme scrambled structure and a partially de-naturation in the presence of palladium complex which decreases the fluorescence intensity when tryptophan is exposed to a polar medium. It can also give information about the interaction mechanism of small molecules with proteins (26). Circular dichroism spectroscopy has a wide range of applications in many different fields. It is also noteworthy that the CD spectra rules out possible changes in the secondary structure of the MT in the pres-ence of palladium complex. It is exhibited in the absorp-tion bands of optically active chiral molecules. The CD spectra of the MT in the presence of palladium complex in Figure 6 shows decrease of negative elipticity and thus the reduction of regular secondary structure of the en-zyme. It is concluded that the incubation of the MT with palladium complex not only induced enzyme inhibition activity but also led to its structural and thermo-dynam-ical instability. Moreover, comparison of the Ki values of palladium complex inhibition on the MT emphasizes that it inhibits the cresolase activity more strongly than 
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the catecholase activity. The current work may assist to design inhibitors to prevent skin disorders such as unde-sirable hyper pigmentation and treatment of melanoma as the major skin cancer.
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